Cargando…
A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain
BACKGROUND: There is a critical need for proven drugs other than non-steroidal anti-inflammatory drugs for treatment of degenerative joint disease (DJD) pain in dogs. Antibodies against nerve growth factor (NGF) are analgesic in rodent models and in humans with DJD. This pilot study aimed to evaluat...
Autores principales: | Lascelles, B Duncan X, Knazovicky, David, Case, Beth, Freire, Mila, Innes, John F, Drew, Alexander C, Gearing, David P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419463/ https://www.ncbi.nlm.nih.gov/pubmed/25926287 http://dx.doi.org/10.1186/s12917-015-0413-x |
Ejemplares similares
-
A Pilot, Open-Label Study to Evaluate the Efficacy of Intra-Articular Administration of a Caninized TNF Receptor Fc Fusion Protein as a Treatment for Osteoarthritis-Associated Joint Pain
por: Nakanishi, Aoi, et al.
Publicado: (2022) -
Initial evaluation of nighttime restlessness in a naturally occurring canine model of osteoarthritis pain
por: Knazovicky, David, et al.
Publicado: (2015) -
Widespread somatosensory sensitivity in naturally occurring canine model of osteoarthritis
por: Knazovicky, David, et al.
Publicado: (2016) -
Development of a checklist for the detection of degenerative joint
disease-associated pain in cats
por: Enomoto, Masataka, et al.
Publicado: (2020) -
Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats
por: Enomoto, Masataka, et al.
Publicado: (2019)